To address if EGCG counteracts a possible overexpression of NOX2 subunits in MS, rather than direct NOX2 overactivation, we performed qRT-PCR analysis of PBMCs from ECGC-treated and untreated patients. The gene discussed is CYBB; the disease is myeloid sarcoma.